| Company Name: | Alphatec Holdings, Inc. | | Ticker Symbol: | ATEC | | | WWW Address: | www.alphatecspine.com |
| CEO: | Leslie H. Cross | | No. of Employees: | 490 |
| Common Issue Type: | CS | | Business Description: | A medical technology company, which is focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, with a focus on products that treat conditions that affect the aging spine.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 1.95 |  0.02 | 1.85 | 6.99 | 1.93 | 1.99 | 1.86 | 58069 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 188.5 | 96.7 | 1.74 | -0.17 | 0.00 | 0.0 | 0.0 | 2.40 - 1.41 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 1.92 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 188.5 | mil |
| Latest Shares Outstanding | 96.7 | mil |
| Earnings pS (EPS) | -0.17 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 400,567 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 62.0 | mil |
| Float as % of Shares Outstanding | 64.1 | % |
| Foreign Sales | 66 | mil |
| Domestic Sales | 130 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 59.80 | % |
| Research & Devlopment (R&D) as % of Revenue | 7.50 | % |
| Gross Profit Margin | 74.4 | % |
| EBITDA Margin | 7.2 | % |
| Pre-Tax Profit Margin | -9.2 | % |
| Assets Turnover | 0.5 | % |
| Return on Assets (ROA) | -4.5 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -6.0 | % |
| Current Ratio | 2.1 | |
| Leverage Ratio (Assets/Equity) | 1.6 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.17 | |
| LT Debt/Total Capital | 14.0 | % |
| Working Capital pS | 0.66 | $ |
| Cash pS | 0.20 | $ |
| Book-Value pS | 2.48 | $ |
| Tangible Book-Value pS | 0.19 | $ |
| Cash Flow pS | 0.09 | $ |
| Free Cash Flow pS | -0.06 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.77 | |
| Price/Tangible Book Ratio | 10.33 | |
| Price/Cash Flow | 22.0 | |
| Price/Free Cash Flow | -31.2 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -3.5 | 97 | 3,613 | 1,705 |
| 4 Weeks | 2.02 | 1.75 | 1.78 | 7.9 | 102 | 2,949 | 47,191 |
| 13 Weeks | 2.40 | 1.62 | 1.72 | 11.6 | 102 | 2,056 | 123,354 |
| 26 Weeks | 2.40 | 1.41 | 1.56 | 23.1 | 104 | 1,688 | 204,262 |
| 52 Weeks | 2.40 | 1.41 | 1.65 | 16.4 | 92 | 1,571 | 384,930 |
| YTD | 2.40 | 1.55 | - | 16.4 | 100 | 1,637 | 157,115 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 1.94 | 1.91 | 1.96 | 1.80 | 1.77 | 1.74 | 1.97 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 18.72 | 90.7 | 10.07 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 11.05 | NA | 7.74 |
| R&D | 13.42 | NA | -0.15 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 4.1 | 4.1 | -0.7 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | -0.02 | -0.02 | 0.08 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 17.08 |
| Current Ratio | 2.1 |
| Quick Ratio (Acid Test) | 1.1 |
| Liquidity Ratio (Cash) | 0.39 |
| Receivables Turnover | 4.7 |
| Average Collection Period | 77 |
| Working Capital/Equity | 26.5 |
| Working Capital pS | 0.68 |
| Cash-Flow pS | 0.10 |
| Free Cash-Flow pS | -0.08 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.37 |
| Financial Leverage Ratio (Assets/Equity) | 1.6 |
| Debt Ratio | 35.7 |
| Total Debt/Equity (Gearing Ratio) | 0.17 |
| LT Debt/Equity | 0.16 |
| LT Debt/Capital Invested | 27.8 |
| LT Debt/Total Liabilities | 29.3 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 1.88 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 4.67 |
| Tobin's Q Ratio | 0.49 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 20.15 |
| Enterprise Value (EV)/Free Cash Flow | -46.09 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 10.33 |
| Price/Book Ratio - LTM | 0.77 |
| Price/Cash Flow Ratio | 22.0 |
| Price/Free Cash Flow Ratio - LTM | -31.2 |
| Price/Sales Ratio | 0.94 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.41 |
| Current Liabilities pS | 0.59 |
| Tangible Book Value pS - LTM | 0.19 |
| Book Value pS - LTM | 2.48 |
| Capital Invested pS | 2.96 |
| Cash pS - LTM | 0.20 |
| Cash Flow pS - LTM | 0.09 |
| Free Cash Flow pS - LTM | -0.06 |
| Earnings pS (EPS) | -0.17 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -3.98 |
| Free Cash Flow Margin 5YEAR AVG | -13.13 |
| Net Profit Margin | -7.9 |
| Net Profit Margin - 5YEAR AVRG. | -11.8 |
| Equity Productivity | 0.80 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 0.69 |
| Return on Capital Invested (ROCI) | -5.4 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -9.0 |
| Assets Productivity | 0.50 |
| Return on Assets (ROA) | -4.0 |
| Return on Assets (ROA) - 5YEAR AVRG. | -6.6 |
| Gross Profit Margin | 74.4 |
| Gross Profit Margin - 5YEAR AVRG. | 72.6 |
| EBITDA Margin - LTM | 7.2 |
| EBIT Margin - LTM | -6.1 |
| Pre-Tax Profit Margin | -8.5 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -12.7 |
| Effective Tax Rate | 7.0 |
| Effective Tax Rate - 5YEAR AVRG. | 6.6 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 420 |
| Revenue per Employee | 400,567 |
| Net Income per Employee | -31,549 |
| Average Collection Period | 75 |
| Receivables Turnover | 4.7 |
| Day's Inventory Turnover Ratio | 345 |
| Inventory Turnover | 1.0 |
| Inventory/Sales | 25.4 |
| Accounts Payble/Sales | 9.77 |
| Assets/Revenue | 2.00 |
| Net Working Capital Turnover | 3.01 |
| Fixed Assets Turnover | 0.75 |
| Total Assets Turnover | 0.5 |
| Revenue per $ Cash | 8.83 |
| Revenue per $ Plant | 6.46 |
| Revenue per $ Common Equity | 0.80 |
| Revenue per $ Capital Invested | 0.69 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 59.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 60.0 |
| Research & Devlopment (R&D) as % of Revenue | 7.8 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 7.8 |
|
|  
|
| |
 |  |
